News & Insights
Sort By
Client News 9 Results
Client News
|July 24, 2024
Gunderson Dettmer Client JenaValve Enters Agreement to be Acquired by Edwards Lifesciences
Pioneer in the transcatheter treatment of aortic regurgitation (AR), JenaValve Technology, announces its agreement to be acquired by Edwards Lifesciences
Client News
|July 11, 2024
Element Biosciences Announces $277M Series D
Developer of pioneering technologies to empower science, Element Biosciences, announces its $277 million Series D financing led by Wellington Management
Client News
|April 23, 2024
AI Biotech Xaira Therapeutics Emerges from Stealth With $1B in Funding
AI biotechnology company, Xaira Therapeutics, announces $1 billion in committed funding to reinvent drug R&D with generative AI methods.
Firm News 1 result
Firm News
|April 25, 2022
Gunderson Dettmer Recognized in 2022 Mergers and Acquisitions Top Middle-Market Deals of the Year
Gunderson Dettmer was recognized as a winner in the 15th Annual Mergers and Acquisitions Top Middle-Market Deals of the Year for its representation of Foresight Sports in its acquisition by Vista Outdoor and The Athletic in its acquisition by The New York Times, two out of the thirteen winning deals for the categories Media and Consumer Products and Outdoor Recreation.